MolGen announced last Wednesday that it has acquired Dutch automation company Synchron Instrumenten BV, also known as Synchron Lab Automation. With this acquisition MolGen will expand its existing portfolio and its ability to build high-end automation solutions for DNA/RNA purification, library preparation and NGS setup to support MolGen’s reagent business. The custom liquid handling platforms […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today provided an update on partnering discussions for its drug discovery business unit. HTG has pioneered a proprietary platform-based approach that is designed to help improve drug discovery, referred to as transcriptome-informed drug discovery and design. […]
Today, Genovis has acquired the patent rights to a unique DNA polymerase developed by researchers at Uppsala University. The enzyme has potential applications in research, diagnostics and forensics. As a leading developer of enzymes for the life science industry, Genovis has acquired the rights to a new enzyme developed by researchers at Uppsala University, led […]
Provides code-free access to pre-vetted Code Ocean research Capsules, suite of ready-to-use tools, and best-in-class customer support NEW YORK — Code Ocean, the world’s first Reproducible Research Cloud, today introduces the Apps Library containing a wealth of customizable Open Source applications. With 30 pre-vetted Code Ocean Capsules available at launch, addressing biotech and life sciences topics such as […]
Collaboration and distribution agreement with Thermo Fisher Scientific Thermo Fisher Scientific obtains exclusive rights to commercialize Devyser’s post-transplant monitoring portfolio in North America and Europe Devyser Diagnostics AB (publ) today announced that the company has signed an exclusive collaboration and distribution agreement with Thermo Fisher Scientific. The agreement gives Thermo Fisher exclusive rights to commercialize, […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura., “Astellas”), by which Astellas will license a suite of Twist’s VHH antibody libraries to be […]
SAN DIEGO, CA – Element Biosciences, Inc.— developer of an innovative DNA sequencing platform that is disrupting the genomics industry — has signed distribution agreements with companies based in Israel, South Korea, Australia, and the United Arab Emirates to bring its AVITI System to more customers around the world. The strong global demand for AVITI […]
The acquisition extends Excelra’s AI, machine learning, and data science capabilities, and enhances its platform and service portfolio. BOSTON — Gent, Belgium & Hyderabad, India: Excelra, a leading life science data and digital solutions provider, has acquired BISC Global, a bioinformatics and data analytics consulting company with offices across Europe and the USA. The acquisition creates […]
Combination of PacBio’s HiFi Sequencing Capabilities and Form Bio’s Computational Platform and Solutions Helps Biopharma and Academic Researchers Innovate and Accelerates Gene Therapy Product Development DALLAS – Form Bio, the provider of advanced computational life sciences technology, today announced it has joined the PacBio Compatible program. As part of the program, the Form Bio platform […]
SOPHiA GENETICS supports The University of Maryland Medical Center to advance their rare disease research BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that the University of Maryland Medical Center (UMMC) is using SOPHiA GENETICS technology to enhance […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
